News
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
17 Apr 24
News, Penny Stocks, Price Target, Markets, Analyst Ratings, Trading Ideas
RBC Capital Downgrades Marinus Pharma to Sector Perform, Lowers Price Target to $3
17 Apr 24
News, Downgrades, Price Target, Analyst Ratings
Analysts Question Commercial Viability of Marinus' IV Ganaxolone After Interim Analysis Miss
16 Apr 24
Analyst Color, Equities, News, Downgrades, Price Target, Markets, Analyst Ratings, Trading Ideas
The Latest Analyst Ratings For Marinus Pharma
16 Apr 24
Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Marinus Pharma, Maintains $27 Price Target
16 Apr 24
News, Price Target, Reiteration, Analyst Ratings
RBC Capital Downgrades Marinus Pharma to Sector Perform, Lowers Price Target to $3
15 Apr 24
News, Downgrades, Price Target, Analyst Ratings
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
15 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
15 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Monday's Intraday Session
15 Apr 24
Movers
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
15 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Did Epilepsy/Seizure Focused-Marinus Pharmaceuticals Stock Hit 52-Week Low On Monday?
15 Apr 24
Biotech, News, Health Care, Movers, Trading Ideas, General
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings
15 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
15 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Monday's Pre-Market Session
15 Apr 24
Movers
Marinus Pharma Reported Prelim ZTALMY (Ganaxolone) Q1 Net Product Revenue of $7.4M-$7.6M, Cash of $113.3M
15 Apr 24
Earnings, News
Marinus Pharma to Continue Phase 3 RAISE Trial of IV Ganaxolone for Severe Seizure Treatment, Advances with ZTALMY's Successful Launch, Eyes New Drug Application and Optimizes Cash Runway
15 Apr 24
News
Cantor Fitzgerald Reiterates Overweight on Marinus Pharma, Maintains $28 Price Target
10 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Marinus Pharmaceuticals Comments On Ovid Therapeutics' Patent Challenge And Provides Update On Marinus' Post Grant Review
27 Mar 24
News, Legal
Peeling Back The Layers: Exploring Marinus Pharma Through Analyst Insights
26 Mar 24
Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Marinus Pharma, Maintains $27 Price Target
26 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
15 Apr 24
News, Legal, Press Releases
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
15 Apr 24
Press Releases
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
5 Apr 24
Press Releases
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review
27 Mar 24
Press Releases
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
5 Mar 24
Press Releases
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
16 Feb 24
Press Releases